{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:34:30Z","timestamp":1787020470544,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Key Discipline of Jiangsu Province","award":["ZDXK202203"],"award-info":[{"award-number":["ZDXK202203"]}]},{"name":"the Open Project of Key Laboratory of Environmental Medicine Engineering of Ministry of Education","award":["2024EME001"],"award-info":[{"award-number":["2024EME001"]}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82320108003,82170845, 82000740"],"award-info":[{"award-number":["82320108003,82170845, 82000740"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-024-01766-3","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T23:33:15Z","timestamp":1730763195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Increased risk of vascular complications in patients with type 2 diabetes and fatty liver disease"],"prefix":"10.1186","volume":"24","author":[{"given":"Weixia","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoxiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"issue":"10397","key":"1766_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"regional Global","year":"2023","unstructured":"Global regional, national burden of diabetes. From 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of Disease Study 2021. Lancet. 2023;402(10397):203\u201334.","journal-title":"Lancet"},{"issue":"8","key":"1766_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao L, Targher G, Byrne CD, Cao YY, Zheng MH. Current status and future trends of the global burden of MASLD. Trends Endocrinol Metab. 2024;35(8):697\u2013707.","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"1766_CR3","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/jdi.13756","volume":"13","author":"CH Lee","year":"2022","unstructured":"Lee CH, Lui DT, Lam KS. Non-alcoholic fatty liver disease and type 2 diabetes: an update. J Diabetes Investig. 2022;13(6):930\u201340.","journal-title":"J Diabetes Investig"},{"issue":"1","key":"1766_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/liv.15730","volume":"44","author":"R Forlano","year":"2024","unstructured":"Forlano R, Stanic T, Jayawardana S, et al. A prospective study on the prevalence of MASLD in people with type-2 diabetes in the community. Cost effectiveness of screening strategies. Liver Int. 2024;44(1):61\u201371.","journal-title":"Liver Int"},{"issue":"11","key":"1766_CR5","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1136\/gutjnl-2023-330110","volume":"72","author":"E En Li Cho","year":"2023","unstructured":"En Li Cho E, Ang CZ, Quek J, et al. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis. Gut. 2023;72(11):2138\u201348.","journal-title":"Gut"},{"issue":"13","key":"1766_CR6","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1016\/j.cgh.2023.04.026","volume":"21","author":"YG Seo","year":"2023","unstructured":"Seo YG, Polyzos SA, Park KH, Mantzoros CS. Fibrosis-4 Index predicts long-term All-Cause, Cardiovascular and Liver-related mortality in the adult Korean Population. Clin Gastroenterol Hepatol. 2023;21(13):3322\u201335.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"1766_CR7","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1038\/s41467-024-47960-8","volume":"15","author":"Z Liu","year":"2024","unstructured":"Liu Z, Huang H, Xie J, Xu Y, Xu C. Circulating fatty acids and risk of hepatocellular carcinoma and chronic liver disease mortality in the UK Biobank. Nat Commun. 2024;15(1):3707.","journal-title":"Nat Commun"},{"key":"1766_CR8","doi-asserted-by":"crossref","unstructured":"Croce AC, Ferrigno A, Palladini G, Mannucci B, Vairetti M, Di Pasqua LG. Fatty acids and bilirubin as intrinsic autofluorescence serum biomarkers of drug action in a rat model of liver ischemia and reperfusion. Molecules 2023; 28(9).","DOI":"10.3390\/molecules28093818"},{"issue":"4","key":"1766_CR9","first-page":"691","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024;73(4):691\u2013702.","journal-title":"Gut"},{"issue":"2","key":"1766_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/joim.13673","volume":"294","author":"T Ebert","year":"2023","unstructured":"Ebert T, Widman L, Stenvinkel P, Hagstr\u00f6m H. Increased risk for microvascular outcomes in NAFLD-A nationwide, population-based cohort study. J Intern Med. 2023;294(2):216\u201327.","journal-title":"J Intern Med"},{"issue":"9","key":"1766_CR11","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1111\/liv.12840","volume":"35","author":"F Bril","year":"2015","unstructured":"Bril F, Ortiz-Lopez C, Lomonaco R, et al. Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients. Liver Int. 2015;35(9):2139\u201346.","journal-title":"Liver Int"},{"issue":"6","key":"1766_CR12","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1210\/jc.2015-1966","volume":"100","author":"P Portillo-Sanchez","year":"2015","unstructured":"Portillo-Sanchez P, Bril F, Maximos M, et al. High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes Mellitus and normal plasma aminotransferase levels. J Clin Endocrinol Metab. 2015;100(6):2231\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1766_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"issue":"8","key":"1766_CR14","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S2468-1253(23)00141-3","volume":"8","author":"FE M\u00f3zes","year":"2023","unstructured":"M\u00f3zes FE, Lee JA, Vali Y, et al. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(8):704\u201313.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1766_CR15","doi-asserted-by":"publisher","first-page":"100780","DOI":"10.1016\/j.lanepe.2023.100780","volume":"36","author":"QM Anstee","year":"2024","unstructured":"Anstee QM, Berentzen TL, Nitze LM, et al. Prognostic utility of Fibrosis-4 index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and\/or type 2 diabetes: a longitudinal cohort study. Lancet Reg Health Eur. 2024;36:100780.","journal-title":"Lancet Reg Health Eur"},{"issue":"9","key":"1766_CR16","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","volume":"11","author":"EM Koehler","year":"2013","unstructured":"Koehler EM, Schouten JN, Hansen BE, Hofman A, Stricker BH, Janssen HL. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol. 2013;11(9):1201\u20134.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"1766_CR17","doi-asserted-by":"publisher","first-page":"100896","DOI":"10.1016\/j.jhepr.2023.100896","volume":"5","author":"B Ho","year":"2023","unstructured":"Ho B, Thompson A, Jorgensen AL, Pirmohamed M. Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease. JHEP Rep. 2023;5(12):100896.","journal-title":"JHEP Rep"},{"issue":"5","key":"1766_CR18","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797\u2013835.","journal-title":"Hepatology"},{"issue":"9","key":"1766_CR19","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41574-021-00512-2","volume":"17","author":"S Bellary","year":"2021","unstructured":"Bellary S, Kyrou I, Brown JE, Bailey CJ. Type 2 diabetes mellitus in older adults: clinical considerations and management. Nat Rev Endocrinol. 2021;17(9):534\u201348.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"1766_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/nyas.15012","volume":"1526","author":"G Agyapong","year":"2023","unstructured":"Agyapong G, Dashti F, Banini BA. Nonalcoholic liver disease: Epidemiology, risk factors, natural history, and management strategies. Ann N Y Acad Sci. 2023;1526(1):16\u201329.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"1766_CR21","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.14336\/AD.2022.0318","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Adeniji NT, Fan W, Kunimoto K, T\u00f6r\u00f6k NJ. Non-alcoholic fatty liver disease and liver fibrosis during aging. Aging Dis. 2022;13(4):1239\u201351.","journal-title":"Aging Dis"},{"issue":"1","key":"1766_CR22","doi-asserted-by":"publisher","first-page":"e22125","DOI":"10.1096\/fj.202101426R","volume":"36","author":"Y Wan","year":"2022","unstructured":"Wan Y, Li X, Slevin E, et al. Endothelial dysfunction in pathological processes of chronic liver disease during aging. Faseb j. 2022;36(1):e22125.","journal-title":"Faseb j"},{"issue":"12","key":"1766_CR23","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1111\/apt.17997","volume":"59","author":"N Mittal","year":"2024","unstructured":"Mittal N, Siddiqi H, Madamba E, et al. A prospective study on the prevalence of at-risk MASH in patients with type 2 diabetes mellitus in the United States. Aliment Pharmacol Ther. 2024;59(12):1571\u20138.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1766_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrendo.2017.173","volume":"14","author":"G Targher","year":"2018","unstructured":"Targher G, Lonardo A, Byrne CD. Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nat Rev Endocrinol. 2018;14(2):99\u2013114.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"1766_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","volume":"10","author":"N Stefan","year":"2022","unstructured":"Stefan N, Cusi K. A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Lancet Diabetes Endocrinol. 2022;10(4):284\u201396.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"1766_CR26","first-page":"200","volume":"35","author":"C Foster","year":"2024","unstructured":"Foster C, Gagnon CA, Ashraf AP. Altered lipid metabolism and the development of metabolic-associated fatty liver disease. Curr Opin Lipidol. 2024;35(4):200\u20137.","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"1766_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s13071-022-05359-8","volume":"15","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhang P, Li J, et al. Association between serum lipid profile and liver fibrosis in patients infected with Schistosoma Japonicum. Parasit Vectors. 2022;15(1):268.","journal-title":"Parasit Vectors"},{"issue":"7","key":"1766_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1507\/endocrj.EJ18-0505","volume":"66","author":"Y Fujihara","year":"2019","unstructured":"Fujihara Y, Hamanoue N, Yano H, et al. High sex hormone-binding globulin concentration is a risk factor for high fibrosis-4 index in middle-aged Japanese men. Endocr J. 2019;66(7):637\u201345.","journal-title":"Endocr J"},{"issue":"12","key":"1766_CR29","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1097\/MEG.0000000000001461","volume":"31","author":"RF Jaafar","year":"2019","unstructured":"Jaafar RF, Hajj Ali AM, Zaghal AM, et al. Fibroscan and low-density lipoprotein as determinants of severe liver fibrosis in diabetic patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2019;31(12):1540\u20134.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"1766_CR30","doi-asserted-by":"publisher","first-page":"101506","DOI":"10.1016\/j.diabet.2023.101506","volume":"50","author":"J Bilson","year":"2024","unstructured":"Bilson J, Mantovani A, Byrne CD, Targher G. Steatotic liver disease, MASLD and risk of chronic kidney disease. Diabetes Metab. 2024;50(1):101506.","journal-title":"Diabetes Metab"},{"issue":"3","key":"1766_CR31","first-page":"533","volume":"73","author":"HH Lee","year":"2024","unstructured":"Lee HH, Lee HA, Kim EJ, et al. Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease. Gut. 2024;73(3):533\u201340.","journal-title":"Gut"},{"issue":"4","key":"1766_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.diabet.2019.11.004","volume":"46","author":"A Mantovani","year":"2020","unstructured":"Mantovani A, Turino T, Lando MG, et al. Screening for non-alcoholic fatty liver disease using liver stiffness measurement and its association with chronic kidney disease and cardiovascular complications in patients with type 2 diabetes. Diabetes Metab. 2020;46(4):296\u2013303.","journal-title":"Diabetes Metab"},{"issue":"10","key":"1766_CR33","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1111\/jgh.15589","volume":"36","author":"N Tamaki","year":"2021","unstructured":"Tamaki N, Kurosaki M, Takahashi Y, et al. Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease. J Gastroenterol Hepatol. 2021;36(10):2960\u20136.","journal-title":"J Gastroenterol Hepatol"},{"key":"1766_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fmed.2019.00202","volume":"6","author":"A Ismaiel","year":"2019","unstructured":"Ismaiel A, Dumitra\u015fcu DL. Cardiovascular risk in fatty liver disease: the Liver-Heart Axis-Literature Review. Front Med (Lausanne). 2019;6:202.","journal-title":"Front Med (Lausanne)"},{"issue":"6660","key":"1766_CR35","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1126\/science.ade4961","volume":"381","author":"JUG Wagner","year":"2023","unstructured":"Wagner JUG, Tombor LS, Malacarne PF, et al. Aging impairs the neurovascular interface in the heart. Science. 2023;381(6660):897\u2013906.","journal-title":"Science"},{"issue":"11","key":"1766_CR36","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s00018-023-04966-7","volume":"80","author":"RI Velliou","year":"2023","unstructured":"Velliou RI, Legaki AI, Nikolakopoulou P, Vlachogiannis NI, Chatzigeorgiou A. Liver endothelial cells in NAFLD and transition to NASH and HCC. Cell Mol Life Sci. 2023;80(11):314.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1766_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12933-022-01516-6","volume":"21","author":"CX Ma","year":"2022","unstructured":"Ma CX, Ma XN, Guan CH, Li YD, Mauricio D, Fu SB. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol. 2022;21(1):74.","journal-title":"Cardiovasc Diabetol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01766-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-024-01766-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-024-01766-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T10:06:21Z","timestamp":1730801181000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-024-01766-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1766"],"URL":"https:\/\/doi.org\/10.1186\/s12902-024-01766-3","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was in accordance to the Declaration of Helsinki and approved by Zhongda Hospital Affiliated to Southeast University Ethics Committee. The requirement to obtain informed written consent was waived. Clinical data of patients were protected and anonymous.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}